Cyclophosphamide/dactinomycin/vincristineLack of efficacy

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2024年 / 2011卷 / 1期

关键词：

D O I：

10.1007/s40278-024-60375-9

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：140 / 140

相关论文

共 50 条

[21] Cyclophosphamide/doxorubicin/vincristineLack of efficacy: case report
Reactions Weekly, 2023, 1973 (1) : 107 - 107
[22] Cyclophosphamide/doxorubicin/prednisone/vincristineLack of efficacy: case report
Reactions Weekly, 2021, 1848 (1) : 139 - 139
[23] Cyclophosphamide/dactinomycin/methotrexateLack of efficacy: case report
Reactions Weekly, 2025, 2043 (1) : 121 - 121
[24] Cyclophosphamide/Doxorubicin/Prednisone/VincristineLack of efficacy: 2 case reports
Reactions Weekly, 2024, 2023 (1) : 125 - 125
[25] Cyclophosphamide/dactinomycin/vincristinePeripheral neuropathy and lack of efficacy: case report
Reactions Weekly, 2022, 1918 (1) : 167 - 167
[26] Bendamustine/Cyclophosphamide/Methotrexate/Prednisone/Rituximab/VincristineLack of efficacy: 2 case reports
Reactions Weekly, 2025, 2050 (1) : 109 - 109
[27] Cyclophosphamide/dactinomycin/vincristineMyelosuppression: case report
Reactions Weekly, 2016, 1624 (1) : 63 - 63
[28] Carboplatin/selumetinib/vincristineLack of efficacy
Reactions Weekly, 2024, 2004 (1) : 123 - 123
[29] Cyclophosphamide/dactinomycin/vincristineThrombocytopenia: case report
Reactions Weekly, 2023, 1943 (1) : 245 - 245
[30] VincristineLack of efficacy: case report
Reactions Weekly, 2023, 1956 (1) : 504 - 504

← 1 2 3 4 5 →